Lack of association between factor V Leiden and prothrombin G20210A polymorphisms in Tunisian subjects with a history of myocardial infarction

Cardiovasc Pathol. 2013 Jan-Feb;22(1):39-41. doi: 10.1016/j.carpath.2012.03.002. Epub 2012 Apr 5.

Abstract

Background: Myocardial infarction is a multifactorial disease. It is provoked by occlusions in the coronary arteries resulting from exposure to multiple risk factors.

Objective: To study the risk of myocardial infarction associated with the gene polymorphisms of factor V Leiden and factor II (G20210A).

Materials and methods: Cases consisted of 100 myocardial infarction patients who were hospitalized in the Principal Military Hospital of Tunis and 200 control subjects with no history of myocardial infarction.

Results: The prevalence of the factor V Leiden was higher in myocardial infarction patients (9%) than in control subjects (6%) with an OR=1.55 (95% CI=0.58-4.12), whereas the prevalence of prothrombin G20210A mutation was 3% and 2.5% in the patient and control groups, respectively [OR=1.21 (95% CI=0.22-5.94)].

Conclusion: Our results indicate that neither factor V Leiden nor the prothrombin G20210A contributed to the risk factors for myocardial infarction.

MeSH terms

  • Adult
  • Case-Control Studies
  • DNA Mutational Analysis
  • Factor V / genetics*
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Hospitals, Military
  • Humans
  • Middle Aged
  • Mutation*
  • Myocardial Infarction / genetics*
  • Odds Ratio
  • Phenotype
  • Polymorphism, Genetic*
  • Prothrombin / genetics*
  • Risk Factors
  • Tunisia
  • Young Adult

Substances

  • factor V Leiden
  • Factor V
  • Prothrombin